Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3

Hillel Yaffe Medical Center120 enrolled

Overview

The aim of this study is to determine the role of human neutrophil peptide-1 to 3 in the occurrence of periprocedural myocardial infarction.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Coronary Thrombosis

Interventions

Blood sampleOTHER

Blood sample drawn from participants for analysis of neutrophil peptide level

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Troponin negative patients * Stable angina * Unstable angina * Positive screening tests Exclusion Criteria: * Troponin positive * Technical failure of procedure * Hemodynamic unstability

Locations (1)

Hillel Yaffe Medical Center

Hadera, Israel

Outcomes

Primary Outcomes

Human Neutrophil Peptide Level

Laboratory analysis and measurement of Human Neutrophil Peptide-1 to 3 levels

Time frame: Two hours

Central Contacts

Rami Abu Fanne, MD, PhD

CONTACT

972-50-3573694 ramia@hadassah.org.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.